Savi trimetazidine 35 MR is known as a drug used in the treatment of angina pectoris containing the main active ingredient, trimetazidine, due to its ability to conserve energy in cardiac muscle cells. However, the indications for using Savi Trimetazidine 35 MR have now changed compared to when the drug was just approved for use in Vietnam.